Independent Cross-Domain Equity Research

Every thesis tested against ten domains of evidence.

We extract what the price embeds, generate competing hypotheses, and monitor which one the accumulating evidence actually supports — across your entire portfolio, continuously.

Latest Research

XRO.AX

Xero Limited

INFORMATION TECHNOLOGY • CLOUD ACCOUNTING

A$84.28

MKT CAP

A$14.1B

FWD P/E

65.3x

REV GROWTH

+20%

SUBSCRIBERS

4.6M

UPSIDE

Stock down 55% on AI disruption concerns,XRO has an entrenched market position, resistent to generative AI.

Coverage initiated 4 Feb 2026

ACTIVE

WOW.AX

Woolworths Group

CONSUMER STAPLES • GROCERY

A$31.41

MKT CAP

A$38.3B

FWD P/E

23.5x

NPAT FY25

↓19%

DIV YIELD

2.9%

DOWNSIDE

Premium multiple pricing turnaround, but FY25 delivered 19% NPAT decline. H1 FY26 is the test.

Coverage initiated 6 Feb 2026

ACTIVE

WTC.AX

WiseTech Global

INFORMATION TECHNOLOGY • LOGISTICS SOFTWARE

A$49.30

MKT CAP

A$18.8B

P/E

55.5x

REV GROWTH

+26%

EBITDA MGN

53.5%

DOWNSIDE

Governance crisis: founder-CEO resigned, board mass departure. Stock down 61% from highs. Product strong but leadership risk dominates.

Coverage initiated 7 Feb 2026

ACTIVE

PME.AX

Pro Medicus

HEALTHCARE IT • MEDICAL IMAGING

A$166.35

MKT CAP

A$18.6B

P/E

163x

REV GROWTH

+32%

EBITDA MGN

77%

UPSIDE

Exceptional business: 77% EBITDA margins, zero debt, A$520M new contracts FY25. US market share only 10%. Extreme valuation but extraordinary economics.

Coverage initiated 8 Feb 2026

ACTIVE

DRO.AX

DroneShield

DEFENCE TECHNOLOGY • COUNTER-UAS

A$2.90

MKT CAP

A$2.66B

REV GROWTH

+210%

GROSS MGN

65%

CASH

A$204M

BALANCED

Record revenue growth and strong defence tailwinds, but pipeline contraction from A$2.55B to A$2.09B and insider selling create offsetting signals.

Coverage initiated 10 Feb 2026

ACTIVE

GYG.AX

Guzman y Gomez

CONSUMER DISCRETIONARY • QSR

A$20.30

MKT CAP

A$2.08B

P/E

166x

REV GROWTH

+27%

STORES

239

DOWNSIDE

Post-IPO correction: trading near A$22 IPO price after peaking at A$46. US losses widening, same-store sales decelerating to 3.7% vs 7.6% forecast.

Coverage initiated 9 Feb 2026

ACTIVE

RMC.AX

Resimac Group

FINANCIALS • NON-BANK LENDING

A$1.17

MKT CAP

A$463M

P/B

1.17x

ROE 1H26

15.5%

NIM

161bps

DOWNSIDE

Smallest listed non-bank lender. 1H26 EBIT +163% driven by RBA rate cuts, not operational improvement. Organic growth 4% vs 25% sector. 63.56% controlling shareholder.

Coverage initiated 2 Mar 2026

ACTIVE
Request AccessFull research reports available to institutional partners.

Coverage Universe

XROXero Limited
A$84.28
Information Technology
ACTIVEUPSIDE
WOWWoolworths Group
A$31.41
Consumer Staples
ACTIVEDOWNSIDE
WTCWiseTech Global
A$49.30
Information Technology
ACTIVEDOWNSIDE
PMEPro Medicus
A$166.35
Healthcare IT
ACTIVEUPSIDE
DRODroneShield
A$2.90
Defence Technology
ACTIVEBALANCED
GYGGuzman y Gomez
A$20.30
Consumer Discretionary
ACTIVEDOWNSIDE
RMCResimac Group
A$1.17
Financials
ACTIVEDOWNSIDE
CSLCSL Limited
A$282.00
Healthcare
PIPELINEBALANCED
BHPBHP Group
A$39.50
Materials
PIPELINEDOWNSIDE
CBACommonwealth Bank
A$158.00
Financials
PIPELINEBALANCED
WDSWoodside Energy
A$22.80
Energy
PIPELINEUPSIDE

Seven positions under active coverage. More in the pipeline.

Each with competing hypotheses, ten evidence domains monitored, and every claim traced to its source document. This is what Continuum produces.

Request Access